120 related articles for article (PubMed ID: 26807256)
1. Association of Wilms' tumor 1 gene single-nucleotide polymorphism rs16754 with colorectal cancer.
Sangkhathat S; Maneechay W; Chaiyapan W; Kanngern S; Boonpipattanapong T
Mol Clin Oncol; 2015 Nov; 3(6):1401-1405. PubMed ID: 26807256
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia.
Choi Y; Lee JH; Hur EH; Kang MJ; Kim SD; Lee JH; Kim DY; Lim SN; Bae KS; Lim HS; Seol M; Kang YA; Lee KH
Ann Hematol; 2012 May; 91(5):671-677. PubMed ID: 22015946
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Becker H; Maharry K; Radmacher MD; Mrózek K; Metzeler KH; Whitman SP; Schwind S; Kohlschmidt J; Wu YZ; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Moore JO; Caligiuri MA; Larson RA; Marcucci G; Bloomfield CD
Haematologica; 2011 Oct; 96(10):1488-95. PubMed ID: 21659357
[TBL] [Abstract][Full Text] [Related]
4. Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
Junghanns AS; Wittig S; Woehlecke C; Lehmann T; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2221-8. PubMed ID: 26224397
[TBL] [Abstract][Full Text] [Related]
5. WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
Ho PA; Kuhn J; Gerbing RB; Pollard JA; Zeng R; Miller KL; Heerema NA; Raimondi SC; Hirsch BA; Franklin JL; Lange B; Gamis AS; Alonzo TA; Meshinchi S
J Clin Oncol; 2011 Feb; 29(6):704-11. PubMed ID: 21189390
[TBL] [Abstract][Full Text] [Related]
6. WT1 mutations and single nucleotide polymorphism rs16754 analysis of patients with pediatric acute myeloid leukemia in a Chinese population.
Chen X; Yang Y; Huang Y; Tan J; Chen Y; Yang J; Dou H; Zou L; Yu J; Bao L
Leuk Lymphoma; 2012 Nov; 53(11):2195-204. PubMed ID: 22506617
[TBL] [Abstract][Full Text] [Related]
7. Association between the Wilms tumor-1 rs16754 polymorphism and acute myeloid leukemia: A MOOSE-compliant meta-analysis.
Yu X; Zhang Y; Liu S; Mu Y; Shang F; Zhang N
Medicine (Baltimore); 2020 Jul; 99(27):e20713. PubMed ID: 32629644
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma.
Li X; Wang S; Sitaram RT; Andersson C; Ljungberg B; Li A
PLoS One; 2013; 8(3):e58396. PubMed ID: 23484026
[TBL] [Abstract][Full Text] [Related]
9. Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm.
Kim N; Kim IS; Chang CL; Kang JE; Lee EY; Shin HJ
Ann Lab Med; 2015 May; 35(3):348-51. PubMed ID: 25932444
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia.
Petiti J; Rosso V; Lo Iacono M; Calabrese C; Signorino E; Gaidano V; Berger M; Saglio G; Cilloni D
Leuk Res; 2018 Apr; 67():6-11. PubMed ID: 29407184
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience.
Toogeh G; Ramzi M; Faranoush M; Amirizadeh N; Haghpanah S; Moghadam M; Cohan N
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e21-6. PubMed ID: 26725263
[TBL] [Abstract][Full Text] [Related]
12. The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis.
Long J; Fang S; Dai Q; Liu X; Zhu W; Wang S
Oncotarget; 2016 May; 7(22):32079-87. PubMed ID: 26992216
[TBL] [Abstract][Full Text] [Related]
13.
Koczkodaj D; Zmorzyński S; Grygalewicz B; Pieńkowska-Grela B; Styk W; Popek-Marciniec S; Filip AA
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407481
[TBL] [Abstract][Full Text] [Related]
14. Association between WT1 polymorphisms and susceptibility to breast cancer: results from a case-control study in a southwestern Chinese population.
Qi XW; Zheng XD; Zong BG; Chen QQ; Zhang F; Yang XH; Zhang Y; Liu JL; Jiang J
Am J Cancer Res; 2015; 5(3):1234-50. PubMed ID: 26046002
[TBL] [Abstract][Full Text] [Related]
15. [Association of WT1 rs16754 polymorphism with clinical features and prognosis in patients with acute myeloid leukemia].
Xu J; Li L; Li J; Chen Y; Wang HW
Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):898-902. PubMed ID: 27801325
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer.
Miyata Y; Kumagai K; Nagaoka T; Kitaura K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
Cancer Biomark; 2015; 15(6):789-97. PubMed ID: 26406403
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia.
Gaur GC; Ramadan SM; Cicconi L; Noguera NI; Luna I; Such E; Lavorgna S; Di Giandomenico J; Sanz MA; Lo-Coco F
Ann Hematol; 2012 Dec; 91(12):1855-60. PubMed ID: 22895555
[TBL] [Abstract][Full Text] [Related]
18. Description of mutation spectrum and polymorphism of Wilms' tumor 1 (WT1) gene in hypospadias patients in the Indonesian population.
Diposarosa R; Pamungkas KO; Sribudiani Y; Herman H; Suciati LP; Rahayu NS; Effendy SH
J Pediatr Urol; 2018 Jun; 14(3):237.e1-237.e7. PubMed ID: 29958641
[TBL] [Abstract][Full Text] [Related]
19. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
Huang B; Liu X; Sun C; Wang L; Yang L
Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
[TBL] [Abstract][Full Text] [Related]
20. The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia.
Niavarani A; Horswell S; Sadri R; Bonnet D
Ann Hematol; 2016 Jan; 95(2):179-90. PubMed ID: 26499507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
